Geeta Srivastava

Geeta Srivastava is a seasoned professional in pharmaceutical development and chemistry with extensive experience in leadership roles. Currently serving as Senior Director, CMC at Oryn Therapeutics, LLC since 2021, Geeta has previously held positions such as Director of Pharmaceutical Development & CMC and Associate Director of Pharmaceutical Development & CMC at KindredBio Sciences from 2014 to 2021. Prior to that, Geeta worked at Cubist Pharmaceuticals and Optimer Pharmaceuticals, where the role included Associate Director of Pharmaceutical Development, CMC & Commercial Manufacturing from 2004 to 2014. Geeta's career began at the Alberta Research Council, working as a Senior Research Investigator in R&D and pharmaceutical development from 1992 to 2003. Educational credentials include a Ph.D. in Chemistry and a Master's degree in Chemistry from Banaras Hindu University, along with a Bachelor's degree in Chemistry, Zoology, and Botany from the same institution, and a Post Doctorate Fellowship from the University of Alberta.